polyomavirus program (Enyo Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namepolyomavirus program (Enyo Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPolyomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesENYO Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesENYO Pharma Sa
Active IndicationsN/A
Inactive IndicationsPolyomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A